Founder convertible notes
$600,570 principal
Founder-affiliated entities supplied $300,285 each; the notes converted into seed preferred shares in November 2019.
CapitalTime MachineAviation · ACHR
Archer’s private financing included founder notes, a seed round and Series A before its Atlas Crest combination. The preferred-share prices and final merger exchange ratio are documented.
Starting price: $0.33 · Nov–Dec 2019 · issuance period
1.00656519 ACHR share equivalents per starting share at your ending date.
Uses documented share adjustments through 2021-09-17. Assumes the share basis remains comparable after that date; other distributions are excluded.
DOCUMENTED PRIVATE PRICE → YOUR PRICE
Your starting price is ready. Add an ending share price, then select Calculate.
Each preferred share became one legacy common share, then 1.00656519 public shares at closing. This uses the final closing ratio, not a proposed ratio from an earlier S-4.
Formula: amount ÷ $0.33 × 1.00656519 × ACHR ending price.
Final amended 2021 Form S-4 ↗2021 Form 10-K ↗Illustrative paper value; no sale or access to a historical investment is assumed. Excludes fees, taxes, cash dividends, warrants and other distributions; fractional shares assumed. An entered ending price is unverified.
Archer’s private financing included founder notes, a seed round and Series A before its Atlas Crest combination. The preferred-share prices and final merger exchange ratio are documented.
$600,570 principal
Founder-affiliated entities supplied $300,285 each; the notes converted into seed preferred shares in November 2019.
$5.4 million cash purchase price$0.33 per preferred share
November–December: 16,363,635 cash-purchased shares at $0.33, plus 1,829,880 shares from note conversion.
$5 million principal
Marc Lore supplied $3 million and the two founders $1 million each. Principal and interest converted in the Series A.
$50.4 million cash purchase price$1.2046 per preferred share
July–October: 41,872,399 cash-purchased shares at $1.2046; 4,395,023 additional shares arose from note conversion.
$857.6 million gross
Gross proceeds of $857.6 million included $600 million PIPE. Final legacy-common exchange ratio: 1.00656519.
Public trading followed the merger; the SPAC financing is not a conventional operating-company IPO.
Research reviewed 2026-09-24. Selected public records, not a complete private cap table. An undisclosed price is left unknown.
Open this company’s sourced data (JSON) ↗
Final amended 2021 Form S-4 ↗
Certain relationships and related-party transactions: founder notes, 2019 notes, seed and Series A financings; preferred-stock conversion terms.
2021 Form 10-K ↗
Note 3: closing September 16, 2021; final exchange ratio 1.00656519 and recapitalization.
Business combination closing announcement ↗
September 16, 2021: $857.6 million gross proceeds including $600 million PIPE; trading September 17.